These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9178173)

  • 1. Expression and mutations of p53 in salivary gland tumours.
    Kärjä VJ; Syrjänen KJ; Kurvinen AK; Syrjänen SM
    J Oral Pathol Med; 1997 May; 26(5):217-23. PubMed ID: 9178173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low p53 protein expression in salivary gland tumours compared with lung carcinomas.
    Soini Y; Kamel D; Nuorva K; Lane DP; Vähäkangas K; Pääkkö P
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):415-20. PubMed ID: 1333678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours.
    Alves FA; Pires FR; De Almeida OP; Lopes MA; Kowalski LP
    Int J Oral Maxillofac Surg; 2004 Sep; 33(6):593-7. PubMed ID: 15308260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of DNA content in salivary gland tumors].
    Yáñez M; Roa I; Villaseca M; Fuentealba P
    Rev Med Chil; 1997 Oct; 125(10):1177-81. PubMed ID: 9609036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands.
    Kiyoshima T; Shima K; Kobayashi I; Matsuo K; Okamura K; Komatsu S; Rasul AM; Sakai H
    Oral Oncol; 2001 Apr; 37(3):315-22. PubMed ID: 11287288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 mutations in salivary gland neoplasms.
    Matizonkas-Antonio LF; de Mesquita RA; de Souza SC; Nunes FD
    Braz Dent J; 2005; 16(2):162-6. PubMed ID: 16475613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma.
    Papadaki H; Finkelstein SD; Kounelis S; Bakker A; Swalsky PA; Kapadia SB
    Hum Pathol; 1996 Jun; 27(6):567-72. PubMed ID: 8666366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-erbB-2 oncogene expression in salivary gland tumours.
    Kärjä V; Syrjänen S; Kataja V; Syrjänen K
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(4):206-12. PubMed ID: 7915830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
    Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
    Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands.
    Nagel H; Laskawi R; Eiffert H; Schlott T
    Mol Pathol; 2003 Aug; 56(4):226-31. PubMed ID: 12890744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [p53 gene mutation determined by single-strand conformational polymorphism and DNA sequencing analysis in pleomorphic adenoma of salivary gland].
    Wang J; Dong F; Yong P
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):298-300. PubMed ID: 11776898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of DNA microsatellite loci in salivary gland tumours: comparison with immunohistochemical detection of hMSH2 and p53 proteins.
    Ohki K; Kumamoto H; Ichinohasama R; Suzuki M; Yamaguchi T; Echigo S; Motegi K; Ooya K
    Int J Oral Maxillofac Surg; 2001 Dec; 30(6):538-44. PubMed ID: 11829237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and mutation patterns of p53 in benign and malignant salivary gland tumors.
    Nordkvist A; Röijer E; Bang G; Gustafsson H; Behrendt M; Ryd W; Thoresen S; Donath K; Stenman G
    Int J Oncol; 2000 Mar; 16(3):477-83. PubMed ID: 10675478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of TP53 mutations in benign and malignant salivary gland neoplasms.
    Gomes CC; Diniz MG; Orsine LA; Duarte AP; Fonseca-Silva T; Conn BI; De Marco L; Pereira CM; Gomez RS
    PLoS One; 2012; 7(7):e41261. PubMed ID: 22829934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumour suppressor p53 gene sequence mutations in pleomorphic adenoma of salivary gland].
    Wang J; Dong F; Yong P
    Zhonghua Yi Xue Za Zhi; 1999 Oct; 79(10):777-9. PubMed ID: 11715527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implication of CD166 expression in salivary gland tumor.
    Andisheh-Tadbir A; Ashraf MJ; Khademi B; Ahmadi S
    Tumour Biol; 2015 Apr; 36(4):2793-9. PubMed ID: 25472586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland.
    Vila L; Liu H; Al-Quran SZ; Coco DP; Dong HJ; Liu C
    Mod Pathol; 2009 Oct; 22(10):1296-302. PubMed ID: 19617878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of p53 gene mutation in salivary adenoid cystic carcinoma.].
    Zhang DS; Bian CR; Wang PY; Yuan XL; Wang JY
    Shanghai Kou Qiang Yi Xue; 2004 Oct; 13(5):396-8. PubMed ID: 15514865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor (VEGF) expression and microvascular density in salivary gland tumours.
    Faur AC; Lazar E; Cornianu M
    APMIS; 2014 May; 122(5):418-26. PubMed ID: 23937241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary gland tumors in children and adolescents: a clinicopathologic and immunohistochemical study of fifty-three cases.
    da Cruz Perez DE; Pires FR; Alves FA; Almeida OP; Kowalski LP
    Int J Pediatr Otorhinolaryngol; 2004 Jul; 68(7):895-902. PubMed ID: 15183580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.